Not to mention the loan break fees they receive from customers going elsewhere. If their spread is safe then profit on $13.5b is worth considerably more than their market cap.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%